Literature DB >> 51982

Letter: Serum lysozyme in inflammatory bowel disease.

R E Pounder, J R Avella, H McCallum, J J Misiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 51982     DOI： 10.1016/s0140-6736(75)90696-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Serum lysozyme in inflammatory bowel and coeliac disease.

Authors:  E Mallas; J M Terry; P Asquith; W T Cooke
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

2.  Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.

Authors:  O S El-Khatib; O Lebwohl; A A Attia; C A Flood; J A Stein; J G Sweeting; R T Whitlock; E F Osserman; P R Holt
Journal:  Am J Dig Dis       Date:  1978-04

3.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.

Authors:  W Pruzanski; N Marcon; C Ottaway; E Prokipchuk
Journal:  Am J Dig Dis       Date:  1977-11

Review 5.  Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Authors:  T L Peeters; G Vantrappen; K Geboes
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

6.  Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.

Authors:  M Klockars; S Reitamo; J J Reitamo; C Möller
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

7.  Lysozyme: a brief review.

Authors:  M A Mir
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

8.  Serum and faecal lysozyme in inflammatory bowel disease.

Authors:  H J Klass; G Neale
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

9.  Studies on the agent of infectious hepatitis; propagation of the agent in tissue culture and in the embryonated hen's egg.

Authors:  W HENLE; S HARRIS; G HENLE; T N HARRIS; M E DRAKE; F MANGOLD; J STOKES
Journal:  J Exp Med       Date:  1950-09       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.